应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TMDX TransMedics Group Inc.
休市中 07-11 16:00:00 EDT
112.46
-12.32
-9.87%
盘后
113.00
+0.54
+0.48%
19:59 EDT
最高
123.50
最低
109.59
成交量
255.66万
今开
122.70
昨收
124.78
日振幅
11.15%
总市值
38.05亿
流通市值
36.92亿
总股本
3,383万
成交额
2.92亿
换手率
7.79%
流通股本
3,283万
市净率
14.29
ROE
22.99%
每股收益
1.41
52周最高
177.37
52周最低
55.00
市盈率
79.83
股息
0.00
股息收益率
0.00
ROA
4.20%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Piper Sandler:重申TransMedics Group(TMDX.US)评级,由增持调整至增持评级, 目标价由125.00美元调整至145.00美元。
金融界 · 06-04
Piper Sandler:重申TransMedics Group(TMDX.US)评级,由增持调整至增持评级, 目标价由125.00美元调整至145.00美元。
异动解读 | TransMedics集团股价盘中大涨6.80%,分析师上调目标价
异动解读 · 05-12
异动解读 | TransMedics集团股价盘中大涨6.80%,分析师上调目标价
异动解读 | 分析师上调目标价,TransMedics Group盘中大涨6.80%
异动解读 · 05-12
异动解读 | 分析师上调目标价,TransMedics Group盘中大涨6.80%
奥本海默:维持TransMedics Group(TMDX.US)评级,由优于大市调整至优于大市评级, 目标价由125.00美元调整至130.00美元。
金融界 · 05-09
奥本海默:维持TransMedics Group(TMDX.US)评级,由优于大市调整至优于大市评级, 目标价由125.00美元调整至130.00美元。
异动解读 | TransMedics集团股价盘中大涨27.95%,超预期业绩和分析师上调目标价提振信心
异动解读 · 05-09
异动解读 | TransMedics集团股价盘中大涨27.95%,超预期业绩和分析师上调目标价提振信心
异动解读 | TransMedics一季度业绩超预期,盘前大涨16.81%
异动解读 · 05-09
异动解读 | TransMedics一季度业绩超预期,盘前大涨16.81%
异动解读 | 财报超预期,TransMedics Group夜盘大涨14.43%
异动解读 · 05-09
异动解读 | 财报超预期,TransMedics Group夜盘大涨14.43%
异动解读 | 业绩超预期,TransMedics Group盘后大涨9.33%
异动解读 · 05-08
异动解读 | 业绩超预期,TransMedics Group盘后大涨9.33%
TransMedics Gr(TMDX.US):2025年Q1财报实现营收1.435亿美元,前值为9685万美元,预期值为1.234亿美元;每股收益为0.70美元,前值为0.35美元,预期值为0.24美元。
金融界 · 05-08
TransMedics Gr(TMDX.US):2025年Q1财报实现营收1.435亿美元,前值为9685万美元,预期值为1.234亿美元;每股收益为0.70美元,前值为0.35美元,预期值为0.24美元。
异动解读 | TransMedics Group(TMDX)股价盘中大涨6.77%,业绩表现出色成为主因
异动解读 · 02-28
异动解读 | TransMedics Group(TMDX)股价盘中大涨6.77%,业绩表现出色成为主因
异动解读 | TransMedics Group第四季度业绩超预期,股价盘前大涨6.07%
异动解读 · 02-28
异动解读 | TransMedics Group第四季度业绩超预期,股价盘前大涨6.07%
异动解读 | TransMedics Group第四季度业绩超预期,股价应声大涨8.08%
异动解读 · 02-28
异动解读 | TransMedics Group第四季度业绩超预期,股价应声大涨8.08%
异动解读 | TransMedics Group第四季度业绩超预期,盘后股价大涨9.57%
异动解读 · 02-27
异动解读 | TransMedics Group第四季度业绩超预期,盘后股价大涨9.57%
TransMedics Gr 第四季度每股收益 $0.19 超过预估 $0.16,销售额 $121.62M 超过预估 $110.29M
财报速递 · 02-27
TransMedics Gr 第四季度每股收益 $0.19 超过预估 $0.16,销售额 $121.62M 超过预估 $110.29M
Transmedics Group, Inc.盘中异动 大幅上涨5.11%
市场透视 · 02-19
Transmedics Group, Inc.盘中异动 大幅上涨5.11%
Transmedics Group, Inc.盘中异动 早盘股价大涨5.08%报75.85美元
市场透视 · 02-18
Transmedics Group, Inc.盘中异动 早盘股价大涨5.08%报75.85美元
Transmedics Group, Inc.盘中异动 股价大跌5.05%报68.93美元
市场透视 · 02-10
Transmedics Group, Inc.盘中异动 股价大跌5.05%报68.93美元
Needham:重申TransMedics Gr(TMDX.US)评级,由持有调整至持有评级。
金融界 · 02-05
Needham:重申TransMedics Gr(TMDX.US)评级,由持有调整至持有评级。
Transmedics Group, Inc.盘中异动 大幅拉升5.02%报72.21美元
市场透视 · 02-04
Transmedics Group, Inc.盘中异动 大幅拉升5.02%报72.21美元
Transmedics Group, Inc.盘中异动 快速拉升5.09%报64.18美元
市场透视 · 01-28
Transmedics Group, Inc.盘中异动 快速拉升5.09%报64.18美元
加载更多
公司概况
公司名称:
TransMedics Group Inc.
所属市场:
NASDAQ
上市日期:
2019-05-02
主营业务:
TransMedics Group, Inc.于1998年8月注册。该公司是一家商业阶段医疗技术公司,为多个疾病状态的终末期器官衰竭患者提供器官移植治疗。该公司开发了接触网,以取代几十年来的护理标准。该公司创新的接触网技术复制了人体外器官自然生活和功能环境的许多方面。OCS代表了一种方式的转变,将器官移植保存从静态状态转变为动态环境,从而实现新的功能,包括器官优化和评估。
发行价格:
16.00
{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group Inc.","latestPrice":112.46,"timestamp":1752264000000,"preClose":124.78,"halted":0,"volume":2556635,"hourTrading":{"tag":"盘后","latestPrice":113,"preClose":112.46,"latestTime":"19:59 EDT","volume":24722,"amount":2813137.3603,"timestamp":1752278394873},"delay":0,"floatShares":32830491,"shares":33833788,"eps":1.408825,"marketStatus":"休市中","change":-12.32,"latestTime":"07-11 16:00:00 EDT","open":122.7,"high":123.4999,"low":109.59,"amount":292061059.74385,"amplitude":0.111475,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":1.408825,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1556769600000,"exchange":"NASDAQ","adjPreClose":124.78,"preHourTrading":{"tag":"盘前","latestPrice":123.11,"preClose":124.78,"latestTime":"09:29 EDT","volume":4321,"amount":534617.0213,"timestamp":1752240580123},"postHourTrading":{"tag":"盘后","latestPrice":113,"preClose":112.46,"latestTime":"19:59 EDT","volume":24722,"amount":2813137.3603,"timestamp":1752278394873},"volumeRatio":4.127111550936907,"impliedVol":0.9671,"impliedVolPercentile":0.768},"requestUrl":"/m/hq/s/TMDX","defaultTab":"news","newsList":[{"id":"2541709355","title":"Piper Sandler:重申TransMedics Group(TMDX.US)评级,由增持调整至增持评级, 目标价由125.00美元调整至145.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2541709355","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541709355?lang=zh_cn&edition=full","pubTime":"2025-06-05 01:44","pubTimestamp":1749059041,"startTime":"0","endTime":"0","summary":"Piper Sandler:重申TransMedics Group(TMDX.US)评级,由增持调整至增持评级, 目标价由125.00美元调整至145.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/05014450866307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TMDX"],"gpt_icon":0},{"id":"1188428107","title":"异动解读 | TransMedics集团股价盘中大涨6.80%,分析师上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1188428107","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188428107?lang=zh_cn&edition=full","pubTime":"2025-05-13 04:32","pubTimestamp":1747081951,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc.今日盘中表现强劲,股价大涨6.80%,引起投资者广泛关注。该公司专注于开发创新的器官移植技术,近期业绩表现亮眼,获得华尔街分析师的积极评价。根据最新财报数据,TransMedics集团实现营业收入1.44亿美元,净利润2568万美元,每股收益0.76美元。此外,知名投资银行奥本海默近期维持了对TransMedics的\"优于大市\"评级,并将目标价从125美元上调至130美元。同时,医疗器械行业整体呈现上涨趋势,行业内涨幅达1.28%,也为TransMedics的股价上涨提供了有利的市场环境。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"1141753088","title":"异动解读 | 分析师上调目标价,TransMedics Group盘中大涨6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141753088","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141753088?lang=zh_cn&edition=full","pubTime":"2025-05-13 04:32","pubTimestamp":1747081947,"startTime":"0","endTime":"0","summary":"周一盘中,TransMedics Group Inc.股价大幅上涨6.80%,引起市场广泛关注。股价上涨的主要原因是投资银行奥本海默上调了对TransMedics Group的目标价。奥本海默维持对该公司\"优于大市\"的评级,同时将目标价从125.00美元上调至130.00美元。这一积极的分析师评级提振了投资者信心,推动股价上涨。TransMedics Group Inc.是一家专注于器官移植领域的医疗技术公司。根据最新财报数据,TransMedics Group实现营业收入1.44亿美元,净利润2568万美元,每股收益0.76美元,显示出良好的业务增长势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 分析师上调目标价,TransMedics Group盘中大涨6.80%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"2534595274","title":"奥本海默:维持TransMedics Group(TMDX.US)评级,由优于大市调整至优于大市评级, 目标价由125.00美元调整至130.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534595274","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534595274?lang=zh_cn&edition=full","pubTime":"2025-05-10 01:53","pubTimestamp":1746813181,"startTime":"0","endTime":"0","summary":"奥本海默:维持TransMedics Group(TMDX.US)评级,由优于大市调整至优于大市评级, 目标价由125.00美元调整至130.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/10015350281251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TMDX"],"gpt_icon":0},{"id":"1186214275","title":"异动解读 | TransMedics集团股价盘中大涨27.95%,超预期业绩和分析师上调目标价提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1186214275","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186214275?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:51","pubTimestamp":1746798699,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc.今日盘中股价大幅上涨27.95%,引起市场广泛关注。这家先进医疗设备公司的股价飙升主要受到其发布的2025年第一季度财报超出市场预期以及分析师上调目标价的双重利好推动。根据公司公布的财务报告,TransMedics Group在2025年第一季度实现了亮眼的业绩表现。TransMedics的出色业绩表现和积极的市场反应,凸显了公司在器官移植技术领域的领先地位得到进一步巩固,市场对其产品的需求持续增长。这一强劲涨势反映了市场对TransMedics未来发展潜力的认可和信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"1173713456","title":"异动解读 | TransMedics一季度业绩超预期,盘前大涨16.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173713456","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173713456?lang=zh_cn&edition=full","pubTime":"2025-05-09 16:13","pubTimestamp":1746778389,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc.今日盘前大涨16.81%,延续了昨日强劲的上涨势头。这家先进医疗设备公司的股价飙升主要受到其发布的2025年第一季度财报超出市场预期的推动。根据公司公布的财务报告,TransMedics Group在2025年第一季度实现了亮眼的业绩表现:。此外,华尔街分析师对TransMedics的前景持积极态度。TransMedics的出色业绩表现和积极的市场反应,凸显了公司在器官移植技术领域的领先地位得到进一步巩固,市场对其产品的需求持续增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"1170739715","title":"异动解读 | 财报超预期,TransMedics Group夜盘大涨14.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170739715","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170739715?lang=zh_cn&edition=full","pubTime":"2025-05-09 08:17","pubTimestamp":1746749838,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc.在发布2025年第一季度财报后,股价在夜盘交易中大幅上涨14.43%,引起投资者广泛关注。这家先进医疗设备公司的强劲业绩表现远超市场预期,推动了股价的显著上涨。根据公司公布的财务报告,TransMedics Group 2025年第一季度实现营收1.4354亿美元,同比增长48.2%,远超分析师预期的1.2366亿美元。这份亮眼的财报反映了TransMedics Group在器官移植技术领域的领先地位得到进一步巩固,市场对其产品的需求持续增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"1191913678","title":"异动解读 | 业绩超预期,TransMedics Group盘后大涨9.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191913678","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191913678?lang=zh_cn&edition=full","pubTime":"2025-05-09 04:33","pubTimestamp":1746736412,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc.在发布2025年第一季度财报后,股价在盘后交易中大幅上涨9.33%,引起投资者广泛关注。根据公司公布的财务报告,TransMedics Group 2025年第一季度实现营收1.435亿美元,远超分析师预期的1.234亿美元,同时也显著高于去年同期的9685万美元。这份亮眼的财报显示,TransMedics Group在过去一个季度实现了强劲的业务增长和盈利能力提升。公司业绩远超预期可能反映了其在器官移植技术领域的领先地位得到进一步巩固,市场对其产品的需求持续增长。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 业绩超预期,TransMedics Group盘后大涨9.33%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"2534169944","title":"TransMedics Gr(TMDX.US):2025年Q1财报实现营收1.435亿美元,前值为9685万美元,预期值为1.234亿美元;每股收益为0.70美元,前值为0.35美元,预期值为0.24美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534169944","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534169944?lang=zh_cn&edition=full","pubTime":"2025-05-09 04:12","pubTimestamp":1746735140,"startTime":"0","endTime":"0","summary":"TransMedics Gr(TMDX.US):2025年Q1财报实现营收1.435亿美元,前值为9685万美元,预期值为1.234亿美元;每股收益为0.70美元,前值为0.35美元,预期值为0.24美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09041250242984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TMDX"],"gpt_icon":0},{"id":"1137450816","title":"异动解读 | TransMedics Group(TMDX)股价盘中大涨6.77%,业绩表现出色成为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1137450816","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137450816?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:50","pubTimestamp":1740754203,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc.股价今日盘中大涨6.77%,引发了投资者的广泛关注。该公司近期公布的第四季度财报表现出色,成为推动股价上涨的主要因素。根据财报数据显示,TransMedics Group第四季度每股收益达到0.19美元,远高于分析师的平均预期0.16美元。较之去年同期,公司的每股收益和销售额分别大增58.33%和49.83%,充分显示出强劲的业务增长态势。作为一家专注于移植领域的医疗设备公司,TransMedics Group致力开发产品以提高器官贮存、运输和移植效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"1122816460","title":"异动解读 | TransMedics Group第四季度业绩超预期,股价盘前大涨6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122816460","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122816460?lang=zh_cn&edition=full","pubTime":"2025-02-28 17:35","pubTimestamp":1740735317,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc.在盘前交易中,股价大涨6.07%,引发了投资者的广泛关注。公司此前刚刚公布了出色的第四季度财报,成为推动股价上涨的主要利好因素。根据数据显示,TransMedics Group第四季度每股收益为0.19美元,高于分析师预期的0.16美元。该公司专注于移植领域,开发产品旨在提高器官贮存、运输和移植效率。这次业绩表现出色有望进一步提振投资者对公司未来发展的信心,并助力公司在生命科学和器官运输领域扩大市场份额,从而保持良好的业绩增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"1152187718","title":"异动解读 | TransMedics Group第四季度业绩超预期,股价应声大涨8.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152187718","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152187718?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:30","pubTimestamp":1740706254,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc.(TMDX)周四夜盘大涨8.08%,引起了投资界的广泛关注。消息面上,这主要是由于公司刚刚公布的第四季度业绩表现出色所致。\n\n财报数据显示,TransMedics Group第四季度每股收益为0.19美元,超出分析师预期的0.16美元;公司季度销售额达到1.216亿美元,也高于预期的1.103亿美元。相比去年同期,公司的每股收益和销售额分别大增58.33%和49.83%,体现出了良好的业务增长态势。\n\n出色的业绩表现提振了市场对公司未来发展前景的信心,投资者看好该公司继续抓住生命科学和器官运输领域的市场机遇,从而拉动股价呈现上涨走势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"1169240075","title":"异动解读 | TransMedics Group第四季度业绩超预期,盘后股价大涨9.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169240075","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169240075?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:34","pubTimestamp":1740692052,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc. (纳斯达克股票代码:TMDX)盘后股价大涨9.57%,主要受到公司刚刚公布的第四季度业绩表现优异的利好消息影响。\n\n根据公司财报显示,TransMedics Group第四季度每股收益为0.19美元,高于分析师预期的0.16美元。公司同时也录得1.216亿美元的季度销售额,超越预期的1.103亿美元。相比去年同期,公司每股收益和销售额分别增长了58.33%和49.83%。\n\n业绩好于市场预期,显示出公司业务的强劲增长。分析人士预计,这一出色业绩或将帮助公司提振投资者信心,扩大公司在器官运输和生命科学领域的市场份额,从而保持良好发展势头。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TMDX"],"gpt_icon":0},{"id":"1154602585","title":"TransMedics Gr 第四季度每股收益 $0.19 超过预估 $0.16,销售额 $121.62M 超过预估 $110.29M","url":"https://stock-news.laohu8.com/highlight/detail?id=1154602585","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154602585?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:10","pubTimestamp":1740690646,"startTime":"0","endTime":"0","summary":"TransMedics Gr 报告称季度每股收益 $0.19,超出分析师共识预估的 $0.16,超出 18.75%。这一数据相比去年同期的每股收益 $0.12 增长了 58.33%。以上内容来自Benzinga Earnings专栏,原文如下:TransMedics Gr reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.16 by 18.75 percent. This is a 58.33 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $121.62 million which beat the analyst consensus estimate of $110.29 million by 10.28 percent. This is a ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TransMedics Gr 第四季度每股收益 $0.19 超过预估 $0.16,销售额 $121.62M 超过预估 $110.29M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX"],"gpt_icon":1},{"id":"2512352344","title":"Transmedics Group, Inc.盘中异动 大幅上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512352344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512352344?lang=zh_cn&edition=full","pubTime":"2025-02-20 03:23","pubTimestamp":1739993019,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日03时23分,Transmedics Group, Inc.股票出现异动,股价快速拉升5.11%。Transmedics Group, Inc.股票所在的医疗器械行业中,整体涨幅为0.75%。其相关个股中,Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Elutia, Inc.涨幅较大,Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Bone Biologics Corp较为活跃,换手率分别为5047.57%、1083.08%、42.88%,振幅较大的相关个股有Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Ainos Inc C/Wts 29/07/2027 ,振幅分别为65.96%、50.00%、40.58%。Transmedics Group, Inc.公司简介:TransMedics Group Inc 是一家商业阶段的医疗技术公司,为多种疾病状态的终末期器官衰竭患者提供器官移植治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220032340988b5f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220032340988b5f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2324357040.USD","OCS","LU2065731478.USD","BK4588","BK4007","BK4585","TMDX","BK4082"],"gpt_icon":0},{"id":"2512162673","title":"Transmedics Group, Inc.盘中异动 早盘股价大涨5.08%报75.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512162673?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:12","pubTimestamp":1739895125,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时12分,Transmedics Group, Inc.股票出现波动,股价大幅上涨5.08%。截至发稿,该股报75.85美元/股,成交量37.6874万股,换手率1.12%,振幅3.59%。Transmedics Group, Inc.股票所在的医疗器械行业中,整体跌幅为0.50%。Transmedics Group, Inc.公司简介:TransMedics Group Inc 是一家商业阶段的医疗技术公司,为多种疾病状态的终末期器官衰竭患者提供器官移植治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219001205988a0f1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219001205988a0f1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCS","LU2324357040.USD","BK4082","TMDX","BK4007","BK4588","LU2065731478.USD","BK4585"],"gpt_icon":0},{"id":"2510866463","title":"Transmedics Group, Inc.盘中异动 股价大跌5.05%报68.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510866463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510866463?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:59","pubTimestamp":1739199592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时59分,Transmedics Group, Inc.股票出现异动,股价快速下挫5.05%。截至发稿,该股报68.93美元/股,成交量22.7216万股,换手率0.68%,振幅5.34%。Transmedics Group, Inc.股票所在的医疗器械行业中,整体涨幅为0.01%。Transmedics Group, Inc.公司简介:TransMedics Group Inc 是一家商业阶段的医疗技术公司,为多种疾病状态的终末期器官衰竭患者提供器官移植治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225952abc9ac3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225952abc9ac3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TMDX","OCS","LU2065731478.USD","BK4588","BK4007","BK4082","BK4585","LU2324357040.USD"],"gpt_icon":0},{"id":"2509406923","title":"Needham:重申TransMedics Gr(TMDX.US)评级,由持有调整至持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509406923","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509406923?lang=zh_cn&edition=full","pubTime":"2025-02-05 18:52","pubTimestamp":1738752748,"startTime":"0","endTime":"0","summary":"Needham:重申TransMedics Gr(TMDX.US)评级,由持有调整至持有评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05185247963843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TMDX"],"gpt_icon":0},{"id":"2508045724","title":"Transmedics Group, Inc.盘中异动 大幅拉升5.02%报72.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508045724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508045724?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:41","pubTimestamp":1738680069,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时41分,Transmedics Group, Inc.股票出现波动,股价大幅上涨5.02%。Transmedics Group, Inc.股票所在的医疗器械行业中,整体跌幅为0.08%。其相关个股中,Dih Holdings Us Inc C/Wts 20/04/2028 、Movano Inc.、Transmedics Group, Inc.涨幅较大,Nanovibronix, Inc.、Bone Biologics Corp、Allurion Technologies, Inc.较为活跃,换手率分别为2.03%、1.98%、1.47%,振幅较大的相关个股有Catheter Precision, Inc.、Allurion Technologies, Inc.、Naya Biosciences, Inc.,振幅分别为12.64%、8.80%、8.56%。Transmedics Group, Inc.公司简介:TransMedics Group Inc 是一家商业阶段的医疗技术公司,为多种疾病状态的终末期器官衰竭患者提供器官移植治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042241099617d932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042241099617d932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4585","BK4007","LU2324357040.USD","TMDX","OCS","BK4588","LU2065731478.USD"],"gpt_icon":0},{"id":"2507854945","title":"Transmedics Group, Inc.盘中异动 快速拉升5.09%报64.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507854945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507854945?lang=zh_cn&edition=full","pubTime":"2025-01-29 01:24","pubTimestamp":1738085054,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日01时24分,Transmedics Group, Inc.股票出现波动,股价大幅上涨5.09%。Transmedics Group, Inc.股票所在的医疗器械行业中,整体跌幅为0.44%。Transmedics Group, Inc.公司简介:TransMedics Group Inc 是一家商业阶段的医疗技术公司,为多种疾病状态的终末期器官衰竭患者提供器官移植治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129012414a23291b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129012414a23291b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2324357040.USD","BK4082","TMDX","BK4588","BK4007","LU2065731478.USD","BK4585","OCS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":-0.1295},{"period":"1month","weight":-0.2129},{"period":"3month","weight":0.3956},{"period":"6month","weight":0.6344},{"period":"1year","weight":-0.2186},{"period":"ytd","weight":0.8037}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TransMedics Group, Inc.于1998年8月注册。该公司是一家商业阶段医疗技术公司,为多个疾病状态的终末期器官衰竭患者提供器官移植治疗。该公司开发了接触网,以取代几十年来的护理标准。该公司创新的接触网技术复制了人体外器官自然生活和功能环境的许多方面。OCS代表了一种方式的转变,将器官移植保存从静态状态转变为动态环境,从而实现新的功能,包括器官优化和评估。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.014205},{"month":2,"riseRate":0.666667,"avgChangeRate":0.165146},{"month":3,"riseRate":0.333333,"avgChangeRate":0.01893},{"month":4,"riseRate":0.666667,"avgChangeRate":0.108774},{"month":5,"riseRate":0.5,"avgChangeRate":0.127373},{"month":6,"riseRate":1,"avgChangeRate":0.158462},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.019557},{"month":8,"riseRate":0.666667,"avgChangeRate":0.052767},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.108718},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.197398},{"month":11,"riseRate":0.833333,"avgChangeRate":0.241666},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003159}],"exchange":"NASDAQ","name":"TransMedics Group Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group Inc.(TMDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TransMedics Group Inc.(TMDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TransMedics Group Inc.,TMDX,TransMedics Group Inc.股票,TransMedics Group Inc.股票老虎,TransMedics Group Inc.股票老虎国际,TransMedics Group Inc.行情,TransMedics Group Inc.股票行情,TransMedics Group Inc.股价,TransMedics Group Inc.股市,TransMedics Group Inc.股票价格,TransMedics Group Inc.股票交易,TransMedics Group Inc.股票购买,TransMedics Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group Inc.(TMDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TransMedics Group Inc.(TMDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}